How Austria ranks within EU countries
Total investment
March 2022
- Total financing under the European Fund for Strategic Investments (EFSI) in Austria amounts to €2.1 billion and is set to trigger €6.8 billion in additional investments
Infrastructure and innovation projects
- 27 approved projects financed by the European Investment Bank (EIB) with EFSI backing
- approximately €1.7 billion in total financing
- set to trigger €5.1 billion in total investment
Small and medium enterprises (SMEs)
- 6 approved agreements with intermediary banks financed by European Investment Fund (EIF) with EFSI backing
- €374 million in total financing
- set to trigger approximately €1.7 billion in investments with some 3,614 SMEs and mid-cap companies expected to benefit from improved access to finance
Examples projects supported by the Investment Plan in Austria
Treating respiratory and ophthalmic conditions: MARINOMED
Marinomed is a Vienna-based biopharmaceutical company which develops innovative therapies for allergy, respiratory and eye diseases. A €15 million loan is supporting the company’s research and clinical trials for treatments for hay fever, conjunctivitis and dry eye using the patented technology they have developed, with the aim of taking them to market.
Hybrid and electric power trains: AVL
A €70 million loan is supporting Austrian power train system developer AVL in its plans to develop hybrid and fully electric power trains. AVL will use the financing to carry out research for the development of electric drives for hybrids and e-vehicles, fuel-cell drive systems and autonomous vehicles, including the necessary measurement, testing and simulation technology. AVL’s sophisticated and customised powertrain system solutions will result in more environmentally-friendly vehicles with reduced CO2 emissions.
Wind energy: WINDKRAFT SIMONSFELD
€48 million in financing is helping bring to life three new wind farms being constructed by Windkraft Simonsfeld in Austria. The new wind farms – Kreuzstetten IV, Dürnkrut II and Hipples II – will have a total capacity of 39 MW. They will generate enough electricity for more than 25,000 households’ consumption. Over the next four years, the company intends to build another 18 wind power plants in Austria, increasing the country's wind energy production even further.
A €25 million loan is supporting Austrian biotech company Apeiron in developing new pharmaceutical products to treat cancer, particularly a rare type affecting children. The company develops its treatments based either on targeted, tumour-specific approaches or on the stimulation of the immune system, engaging the human body’s natural defence mechanisms.
Energy-efficient trains: CITYJET
A €500 million loan is enabling train company ÖBB Personenverkehr AG to purchase around 260 electric trains for regional passenger railway services in Austria. The new trains are more energy efficient than the previous fleet, and they have improved facilities for people with reduced mobility.
Full list of EFSI-backed projects approved by the EIB
Full list of EFSI-backed agreements with financial intermediaries signed by the EIF